nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—UGT1A1—Rifampicin—leprosy	0.156	0.186	CbGbCtD
Naproxen—SLCO1A2—Rifampicin—leprosy	0.115	0.137	CbGbCtD
Naproxen—PTGS2—Thalidomide—leprosy	0.0971	0.115	CbGbCtD
Naproxen—PTGS1—Thalidomide—leprosy	0.082	0.0975	CbGbCtD
Naproxen—PTGS2—Dapsone—leprosy	0.0776	0.0923	CbGbCtD
Naproxen—PTGS1—Dapsone—leprosy	0.0655	0.078	CbGbCtD
Naproxen—CYP2C8—Rifampicin—leprosy	0.0458	0.0545	CbGbCtD
Naproxen—CYP2C8—Dapsone—leprosy	0.0378	0.045	CbGbCtD
Naproxen—CYP1A2—Thalidomide—leprosy	0.0366	0.0436	CbGbCtD
Naproxen—CYP1A2—Rifampicin—leprosy	0.0355	0.0422	CbGbCtD
Naproxen—CYP2C9—Thalidomide—leprosy	0.033	0.0393	CbGbCtD
Naproxen—CYP2C9—Rifampicin—leprosy	0.032	0.038	CbGbCtD
Naproxen—CYP2C9—Dapsone—leprosy	0.0264	0.0314	CbGbCtD
Naproxen—Renal papillary necrosis—Dapsone—leprosy	0.0162	0.101	CcSEcCtD
Naproxen—Pulmonary eosinophilia—Dapsone—leprosy	0.00834	0.0523	CcSEcCtD
Naproxen—Nephrotic syndrome—Dapsone—leprosy	0.00315	0.0198	CcSEcCtD
Naproxen—Lacrimal structural disorder—Thalidomide—leprosy	0.00265	0.0166	CcSEcCtD
Naproxen—Skin necrosis—Thalidomide—leprosy	0.00223	0.014	CcSEcCtD
Naproxen—Pyuria—Thalidomide—leprosy	0.00223	0.014	CcSEcCtD
Naproxen—Albuminuria—Dapsone—leprosy	0.00204	0.0128	CcSEcCtD
Naproxen—Erythema nodosum—Thalidomide—leprosy	0.0018	0.0113	CcSEcCtD
Naproxen—Lacrimal disorder—Thalidomide—leprosy	0.00174	0.0109	CcSEcCtD
Naproxen—Proteinuria—Dapsone—leprosy	0.00173	0.0109	CcSEcCtD
Naproxen—Protein urine present—Dapsone—leprosy	0.00171	0.0107	CcSEcCtD
Naproxen—Aphthous stomatitis—Thalidomide—leprosy	0.00166	0.0104	CcSEcCtD
Naproxen—Neck stiffness—Thalidomide—leprosy	0.00164	0.0103	CcSEcCtD
Naproxen—Nuchal rigidity—Thalidomide—leprosy	0.0015	0.00943	CcSEcCtD
Naproxen—Skin exfoliation—Dapsone—leprosy	0.00145	0.00912	CcSEcCtD
Naproxen—Gastric ulcer—Thalidomide—leprosy	0.00134	0.00842	CcSEcCtD
Naproxen—Enlargement abdomen—Thalidomide—leprosy	0.0013	0.00813	CcSEcCtD
Naproxen—Serum creatinine increased—Thalidomide—leprosy	0.00127	0.00795	CcSEcCtD
Naproxen—Myasthenia—Thalidomide—leprosy	0.00124	0.00778	CcSEcCtD
Naproxen—Nail disorder—Thalidomide—leprosy	0.0012	0.00754	CcSEcCtD
Naproxen—Tooth disorder—Thalidomide—leprosy	0.0012	0.00754	CcSEcCtD
Naproxen—Menstrual disorder—Thalidomide—leprosy	0.00114	0.00718	CcSEcCtD
Naproxen—Neuralgia—Thalidomide—leprosy	0.00112	0.00704	CcSEcCtD
Naproxen—Lung disorder—Thalidomide—leprosy	0.0011	0.00691	CcSEcCtD
Naproxen—Metrorrhagia—Thalidomide—leprosy	0.00109	0.00685	CcSEcCtD
Naproxen—Albuminuria—Thalidomide—leprosy	0.00104	0.00655	CcSEcCtD
Naproxen—Neuritis—Thalidomide—leprosy	0.00104	0.00655	CcSEcCtD
Naproxen—Cholestasis—Thalidomide—leprosy	0.00103	0.00644	CcSEcCtD
Naproxen—Amblyopia—Thalidomide—leprosy	0.00101	0.00633	CcSEcCtD
Naproxen—Skin ulcer—Thalidomide—leprosy	0.001	0.00628	CcSEcCtD
Naproxen—Muscular weakness—Dapsone—leprosy	0.000975	0.00612	CcSEcCtD
Naproxen—Influenza—Dapsone—leprosy	0.000956	0.00599	CcSEcCtD
Naproxen—Pancreatitis—Dapsone—leprosy	0.000937	0.00588	CcSEcCtD
Naproxen—Blood disorder—Thalidomide—leprosy	0.000934	0.00586	CcSEcCtD
Naproxen—Acne—Thalidomide—leprosy	0.000927	0.00581	CcSEcCtD
Naproxen—Apnoea—Thalidomide—leprosy	0.00092	0.00577	CcSEcCtD
Naproxen—Vasodilation—Thalidomide—leprosy	0.000887	0.00557	CcSEcCtD
Naproxen—Proteinuria—Thalidomide—leprosy	0.000887	0.00557	CcSEcCtD
Naproxen—Vasodilation procedure—Thalidomide—leprosy	0.000887	0.00557	CcSEcCtD
Naproxen—Protein urine present—Thalidomide—leprosy	0.000875	0.00549	CcSEcCtD
Naproxen—Photosensitivity reaction—Dapsone—leprosy	0.000872	0.00547	CcSEcCtD
Naproxen—Musculoskeletal stiffness—Thalidomide—leprosy	0.000869	0.00545	CcSEcCtD
Naproxen—Bone disorder—Thalidomide—leprosy	0.000863	0.00541	CcSEcCtD
Naproxen—Cellulitis—Thalidomide—leprosy	0.000857	0.00538	CcSEcCtD
Naproxen—Arthropathy—Thalidomide—leprosy	0.000857	0.00538	CcSEcCtD
Naproxen—Oliguria—Thalidomide—leprosy	0.000846	0.00531	CcSEcCtD
Naproxen—Herpes simplex—Thalidomide—leprosy	0.000846	0.00531	CcSEcCtD
Naproxen—Hyperuricaemia—Thalidomide—leprosy	0.000841	0.00527	CcSEcCtD
Naproxen—Neuropathy peripheral—Dapsone—leprosy	0.000835	0.00524	CcSEcCtD
Naproxen—Hypercholesterolaemia—Thalidomide—leprosy	0.000824	0.00517	CcSEcCtD
Naproxen—Hearing impaired—Thalidomide—leprosy	0.000819	0.00514	CcSEcCtD
Naproxen—Bone pain—Thalidomide—leprosy	0.000814	0.00511	CcSEcCtD
Naproxen—Sinusitis—Dapsone—leprosy	0.000799	0.00501	CcSEcCtD
Naproxen—Coordination abnormal—Thalidomide—leprosy	0.000794	0.00498	CcSEcCtD
Naproxen—Blood uric acid increased—Thalidomide—leprosy	0.000794	0.00498	CcSEcCtD
Naproxen—Neck pain—Thalidomide—leprosy	0.000789	0.00495	CcSEcCtD
Naproxen—Eructation—Thalidomide—leprosy	0.000766	0.00481	CcSEcCtD
Naproxen—Hyperkalaemia—Thalidomide—leprosy	0.000766	0.00481	CcSEcCtD
Naproxen—Pharyngitis—Dapsone—leprosy	0.000759	0.00476	CcSEcCtD
Naproxen—Colitis—Thalidomide—leprosy	0.000749	0.0047	CcSEcCtD
Naproxen—Skin exfoliation—Thalidomide—leprosy	0.000744	0.00467	CcSEcCtD
Naproxen—Blood urea increased—Thalidomide—leprosy	0.000736	0.00462	CcSEcCtD
Naproxen—Aplastic anaemia—Thalidomide—leprosy	0.000732	0.00459	CcSEcCtD
Naproxen—Tinnitus—Dapsone—leprosy	0.000713	0.00447	CcSEcCtD
Naproxen—Oesophagitis—Thalidomide—leprosy	0.000712	0.00447	CcSEcCtD
Naproxen—Lightheadedness—Thalidomide—leprosy	0.000698	0.00438	CcSEcCtD
Naproxen—Pulmonary oedema—Thalidomide—leprosy	0.000694	0.00435	CcSEcCtD
Naproxen—Hypertonia—Thalidomide—leprosy	0.000683	0.00429	CcSEcCtD
Naproxen—Mental disability—Thalidomide—leprosy	0.000677	0.00424	CcSEcCtD
Naproxen—Sepsis—Thalidomide—leprosy	0.000677	0.00424	CcSEcCtD
Naproxen—Erythema—Dapsone—leprosy	0.000666	0.00418	CcSEcCtD
Naproxen—Lymphadenopathy—Thalidomide—leprosy	0.000663	0.00416	CcSEcCtD
Naproxen—Thrombophlebitis—Thalidomide—leprosy	0.000654	0.0041	CcSEcCtD
Naproxen—Diabetes mellitus—Thalidomide—leprosy	0.000651	0.00408	CcSEcCtD
Naproxen—Photosensitivity—Thalidomide—leprosy	0.000645	0.00404	CcSEcCtD
Naproxen—Gastroenteritis—Thalidomide—leprosy	0.000639	0.00401	CcSEcCtD
Naproxen—Deafness—Thalidomide—leprosy	0.000633	0.00397	CcSEcCtD
Naproxen—Vascular purpura—Thalidomide—leprosy	0.000633	0.00397	CcSEcCtD
Naproxen—Eczema—Thalidomide—leprosy	0.00063	0.00395	CcSEcCtD
Naproxen—Vision blurred—Dapsone—leprosy	0.000627	0.00394	CcSEcCtD
Naproxen—Eye pain—Thalidomide—leprosy	0.000627	0.00393	CcSEcCtD
Naproxen—Cardiac failure congestive—Thalidomide—leprosy	0.000624	0.00391	CcSEcCtD
Naproxen—Amnesia—Thalidomide—leprosy	0.000602	0.00378	CcSEcCtD
Naproxen—Dermatitis exfoliative—Thalidomide—leprosy	0.0006	0.00376	CcSEcCtD
Naproxen—Vertigo—Dapsone—leprosy	0.000598	0.00375	CcSEcCtD
Naproxen—Visual disturbance—Thalidomide—leprosy	0.000597	0.00375	CcSEcCtD
Naproxen—Dermatitis bullous—Thalidomide—leprosy	0.000592	0.00371	CcSEcCtD
Naproxen—Purpura—Thalidomide—leprosy	0.000587	0.00368	CcSEcCtD
Naproxen—Cough—Dapsone—leprosy	0.000581	0.00364	CcSEcCtD
Naproxen—Hypoglycaemia—Thalidomide—leprosy	0.00058	0.00364	CcSEcCtD
Naproxen—Cardiac failure—Thalidomide—leprosy	0.00058	0.00364	CcSEcCtD
Naproxen—Diplopia—Thalidomide—leprosy	0.000566	0.00355	CcSEcCtD
Naproxen—Osteoarthritis—Thalidomide—leprosy	0.000566	0.00355	CcSEcCtD
Naproxen—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000566	0.00355	CcSEcCtD
Naproxen—Migraine—Thalidomide—leprosy	0.000557	0.00349	CcSEcCtD
Naproxen—Affect lability—Thalidomide—leprosy	0.000557	0.00349	CcSEcCtD
Naproxen—Mood swings—Thalidomide—leprosy	0.000536	0.00336	CcSEcCtD
Naproxen—Tachycardia—Dapsone—leprosy	0.00053	0.00333	CcSEcCtD
Naproxen—Blood creatinine increased—Thalidomide—leprosy	0.00053	0.00333	CcSEcCtD
Naproxen—Dehydration—Thalidomide—leprosy	0.000526	0.0033	CcSEcCtD
Naproxen—Liver function test abnormal—Thalidomide—leprosy	0.000523	0.00328	CcSEcCtD
Naproxen—Dry skin—Thalidomide—leprosy	0.000519	0.00325	CcSEcCtD
Naproxen—Hypokalaemia—Thalidomide—leprosy	0.000515	0.00323	CcSEcCtD
Naproxen—Breast disorder—Thalidomide—leprosy	0.000511	0.00321	CcSEcCtD
Naproxen—Cramp muscle—Thalidomide—leprosy	0.00051	0.0032	CcSEcCtD
Naproxen—Toxic epidermal necrolysis—Thalidomide—leprosy	0.00051	0.0032	CcSEcCtD
Naproxen—Muscular weakness—Thalidomide—leprosy	0.000499	0.00313	CcSEcCtD
Naproxen—Abdominal distension—Thalidomide—leprosy	0.000492	0.00309	CcSEcCtD
Naproxen—Insomnia—Dapsone—leprosy	0.000491	0.00308	CcSEcCtD
Naproxen—Influenza—Thalidomide—leprosy	0.000489	0.00307	CcSEcCtD
Naproxen—Dysphagia—Thalidomide—leprosy	0.000489	0.00307	CcSEcCtD
Naproxen—Eosinophilia—Thalidomide—leprosy	0.000484	0.00304	CcSEcCtD
Naproxen—Pancreatitis—Thalidomide—leprosy	0.00048	0.00301	CcSEcCtD
Naproxen—Angina pectoris—Thalidomide—leprosy	0.000477	0.00299	CcSEcCtD
Naproxen—Bronchitis—Thalidomide—leprosy	0.00047	0.00295	CcSEcCtD
Naproxen—Pancytopenia—Thalidomide—leprosy	0.000465	0.00291	CcSEcCtD
Naproxen—Pollakiuria—Thalidomide—leprosy	0.000452	0.00283	CcSEcCtD
Naproxen—Photosensitivity reaction—Thalidomide—leprosy	0.000447	0.0028	CcSEcCtD
Naproxen—Gastrointestinal pain—Dapsone—leprosy	0.000444	0.00279	CcSEcCtD
Naproxen—Weight decreased—Thalidomide—leprosy	0.000443	0.00278	CcSEcCtD
Naproxen—Hyperglycaemia—Thalidomide—leprosy	0.000441	0.00277	CcSEcCtD
Naproxen—Pneumonia—Thalidomide—leprosy	0.000439	0.00275	CcSEcCtD
Naproxen—Drowsiness—Thalidomide—leprosy	0.000436	0.00274	CcSEcCtD
Naproxen—Depression—Thalidomide—leprosy	0.000435	0.00273	CcSEcCtD
Naproxen—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000432	0.00271	CcSEcCtD
Naproxen—Acute coronary syndrome—Thalidomide—leprosy	0.00043	0.0027	CcSEcCtD
Naproxen—Abdominal pain—Dapsone—leprosy	0.00043	0.00269	CcSEcCtD
Naproxen—Body temperature increased—Dapsone—leprosy	0.00043	0.00269	CcSEcCtD
Naproxen—Renal failure—Thalidomide—leprosy	0.000429	0.00269	CcSEcCtD
Naproxen—Myocardial infarction—Thalidomide—leprosy	0.000428	0.00268	CcSEcCtD
Naproxen—Neuropathy peripheral—Thalidomide—leprosy	0.000428	0.00268	CcSEcCtD
Naproxen—Stomatitis—Thalidomide—leprosy	0.000425	0.00267	CcSEcCtD
Naproxen—Conjunctivitis—Thalidomide—leprosy	0.000424	0.00266	CcSEcCtD
Naproxen—Sweating—Thalidomide—leprosy	0.000418	0.00262	CcSEcCtD
Naproxen—Haematuria—Thalidomide—leprosy	0.000416	0.00261	CcSEcCtD
Naproxen—Epistaxis—Thalidomide—leprosy	0.000411	0.00258	CcSEcCtD
Naproxen—Sinusitis—Thalidomide—leprosy	0.000409	0.00257	CcSEcCtD
Naproxen—Agranulocytosis—Thalidomide—leprosy	0.000407	0.00255	CcSEcCtD
Naproxen—Rhinitis—Thalidomide—leprosy	0.000393	0.00246	CcSEcCtD
Naproxen—Hepatitis—Thalidomide—leprosy	0.000392	0.00246	CcSEcCtD
Naproxen—Pharyngitis—Thalidomide—leprosy	0.000389	0.00244	CcSEcCtD
Naproxen—Urinary tract disorder—Thalidomide—leprosy	0.000387	0.00243	CcSEcCtD
Naproxen—Oedema peripheral—Thalidomide—leprosy	0.000386	0.00242	CcSEcCtD
Naproxen—Urethral disorder—Thalidomide—leprosy	0.000384	0.00241	CcSEcCtD
Naproxen—Visual impairment—Thalidomide—leprosy	0.000377	0.00237	CcSEcCtD
Naproxen—Erythema multiforme—Thalidomide—leprosy	0.00037	0.00232	CcSEcCtD
Naproxen—Eye disorder—Thalidomide—leprosy	0.000366	0.0023	CcSEcCtD
Naproxen—Tinnitus—Thalidomide—leprosy	0.000365	0.00229	CcSEcCtD
Naproxen—Cardiac disorder—Thalidomide—leprosy	0.000363	0.00228	CcSEcCtD
Naproxen—Angiopathy—Thalidomide—leprosy	0.000355	0.00223	CcSEcCtD
Naproxen—Immune system disorder—Thalidomide—leprosy	0.000354	0.00222	CcSEcCtD
Naproxen—Mediastinal disorder—Thalidomide—leprosy	0.000353	0.00221	CcSEcCtD
Naproxen—Chills—Thalidomide—leprosy	0.000351	0.0022	CcSEcCtD
Naproxen—Arrhythmia—Thalidomide—leprosy	0.00035	0.00219	CcSEcCtD
Naproxen—Alopecia—Thalidomide—leprosy	0.000346	0.00217	CcSEcCtD
Naproxen—Vomiting—Dapsone—leprosy	0.000346	0.00217	CcSEcCtD
Naproxen—Mental disorder—Thalidomide—leprosy	0.000343	0.00215	CcSEcCtD
Naproxen—Malnutrition—Thalidomide—leprosy	0.000341	0.00214	CcSEcCtD
Naproxen—Headache—Dapsone—leprosy	0.00034	0.00214	CcSEcCtD
Naproxen—Flatulence—Thalidomide—leprosy	0.000336	0.00211	CcSEcCtD
Naproxen—Tension—Thalidomide—leprosy	0.000334	0.0021	CcSEcCtD
Naproxen—Nervousness—Thalidomide—leprosy	0.000331	0.00208	CcSEcCtD
Naproxen—Muscle spasms—Thalidomide—leprosy	0.000328	0.00206	CcSEcCtD
Naproxen—Nausea—Dapsone—leprosy	0.000323	0.00202	CcSEcCtD
Naproxen—Vision blurred—Thalidomide—leprosy	0.000321	0.00201	CcSEcCtD
Naproxen—Tremor—Thalidomide—leprosy	0.000319	0.002	CcSEcCtD
Naproxen—Ill-defined disorder—Thalidomide—leprosy	0.000316	0.00198	CcSEcCtD
Naproxen—Anaemia—Thalidomide—leprosy	0.000315	0.00198	CcSEcCtD
Naproxen—Angioedema—Thalidomide—leprosy	0.000311	0.00195	CcSEcCtD
Naproxen—Malaise—Thalidomide—leprosy	0.000307	0.00193	CcSEcCtD
Naproxen—Vertigo—Thalidomide—leprosy	0.000306	0.00192	CcSEcCtD
Naproxen—Syncope—Thalidomide—leprosy	0.000306	0.00192	CcSEcCtD
Naproxen—Leukopenia—Thalidomide—leprosy	0.000305	0.00191	CcSEcCtD
Naproxen—Palpitations—Thalidomide—leprosy	0.000301	0.00189	CcSEcCtD
Naproxen—Loss of consciousness—Thalidomide—leprosy	0.0003	0.00188	CcSEcCtD
Naproxen—Cough—Thalidomide—leprosy	0.000297	0.00187	CcSEcCtD
Naproxen—Convulsion—Thalidomide—leprosy	0.000295	0.00185	CcSEcCtD
Naproxen—Hypertension—Thalidomide—leprosy	0.000294	0.00185	CcSEcCtD
Naproxen—Arthralgia—Thalidomide—leprosy	0.00029	0.00182	CcSEcCtD
Naproxen—Chest pain—Thalidomide—leprosy	0.00029	0.00182	CcSEcCtD
Naproxen—Myalgia—Thalidomide—leprosy	0.00029	0.00182	CcSEcCtD
Naproxen—Anxiety—Thalidomide—leprosy	0.000289	0.00181	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000288	0.00181	CcSEcCtD
Naproxen—Discomfort—Thalidomide—leprosy	0.000287	0.0018	CcSEcCtD
Naproxen—Dry mouth—Thalidomide—leprosy	0.000284	0.00178	CcSEcCtD
Naproxen—Confusional state—Thalidomide—leprosy	0.00028	0.00176	CcSEcCtD
Naproxen—Oedema—Thalidomide—leprosy	0.000278	0.00174	CcSEcCtD
Naproxen—Infection—Thalidomide—leprosy	0.000276	0.00173	CcSEcCtD
Naproxen—Shock—Thalidomide—leprosy	0.000274	0.00172	CcSEcCtD
Naproxen—Nervous system disorder—Thalidomide—leprosy	0.000273	0.00171	CcSEcCtD
Naproxen—Thrombocytopenia—Thalidomide—leprosy	0.000272	0.00171	CcSEcCtD
Naproxen—Tachycardia—Thalidomide—leprosy	0.000271	0.0017	CcSEcCtD
Naproxen—Skin disorder—Thalidomide—leprosy	0.00027	0.00169	CcSEcCtD
Naproxen—Hyperhidrosis—Thalidomide—leprosy	0.000269	0.00169	CcSEcCtD
Naproxen—Anorexia—Thalidomide—leprosy	0.000265	0.00166	CcSEcCtD
Naproxen—Hypotension—Thalidomide—leprosy	0.00026	0.00163	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Thalidomide—leprosy	0.000253	0.00159	CcSEcCtD
Naproxen—Insomnia—Thalidomide—leprosy	0.000252	0.00158	CcSEcCtD
Naproxen—Paraesthesia—Thalidomide—leprosy	0.00025	0.00157	CcSEcCtD
Naproxen—Dyspnoea—Thalidomide—leprosy	0.000248	0.00156	CcSEcCtD
Naproxen—Somnolence—Thalidomide—leprosy	0.000247	0.00155	CcSEcCtD
Naproxen—Dyspepsia—Thalidomide—leprosy	0.000245	0.00154	CcSEcCtD
Naproxen—Decreased appetite—Thalidomide—leprosy	0.000242	0.00152	CcSEcCtD
Naproxen—Gastrointestinal disorder—Thalidomide—leprosy	0.00024	0.00151	CcSEcCtD
Naproxen—Fatigue—Thalidomide—leprosy	0.00024	0.0015	CcSEcCtD
Naproxen—Pain—Thalidomide—leprosy	0.000238	0.00149	CcSEcCtD
Naproxen—Constipation—Thalidomide—leprosy	0.000238	0.00149	CcSEcCtD
Naproxen—Feeling abnormal—Thalidomide—leprosy	0.000229	0.00144	CcSEcCtD
Naproxen—Gastrointestinal pain—Thalidomide—leprosy	0.000227	0.00143	CcSEcCtD
Naproxen—Urticaria—Thalidomide—leprosy	0.000221	0.00139	CcSEcCtD
Naproxen—Body temperature increased—Thalidomide—leprosy	0.00022	0.00138	CcSEcCtD
Naproxen—Abdominal pain—Thalidomide—leprosy	0.00022	0.00138	CcSEcCtD
Naproxen—Hypersensitivity—Thalidomide—leprosy	0.000205	0.00129	CcSEcCtD
Naproxen—Asthenia—Thalidomide—leprosy	0.0002	0.00125	CcSEcCtD
Naproxen—Pruritus—Thalidomide—leprosy	0.000197	0.00123	CcSEcCtD
Naproxen—Diarrhoea—Thalidomide—leprosy	0.00019	0.00119	CcSEcCtD
Naproxen—Dizziness—Thalidomide—leprosy	0.000184	0.00115	CcSEcCtD
Naproxen—Vomiting—Thalidomide—leprosy	0.000177	0.00111	CcSEcCtD
Naproxen—Rash—Thalidomide—leprosy	0.000175	0.0011	CcSEcCtD
Naproxen—Dermatitis—Thalidomide—leprosy	0.000175	0.0011	CcSEcCtD
Naproxen—Headache—Thalidomide—leprosy	0.000174	0.00109	CcSEcCtD
Naproxen—Nausea—Thalidomide—leprosy	0.000165	0.00104	CcSEcCtD
